Pyroptosis-mediator GSDMD promotes Parkinson's disease pathology via microglial activation and dopaminergic neuronal death

被引:6
|
作者
Zhang, Xiaoshuang [1 ,2 ]
Zhang, Yunhe [1 ,2 ]
Wang, Boya [1 ,2 ]
Xie, Chuantong [1 ,2 ]
Wang, Jinghui [1 ,2 ]
Fang, Rong [1 ,2 ]
Dong, Hongtian [1 ,2 ]
Fan, Guangchun [1 ,2 ]
Wang, Mengze [1 ,2 ]
He, Yongtao [1 ,2 ]
Shen, Chenye [1 ,2 ]
Duan, Yufei [1 ,2 ]
Zhao, Jiayin [1 ,2 ]
Liu, Zhaolin [1 ,2 ]
Li, Qing [1 ,2 ]
Ma, Yuanyuan [1 ,2 ]
Yu, Mei [1 ,2 ]
Wang, Jian [1 ,2 ]
Fei, Jian [3 ,4 ,5 ]
Xiao, Lei [1 ,2 ,5 ]
Huang, Fang [1 ,2 ,5 ]
机构
[1] Fudan Univ, Jingan Dist Ctr Hosp Shanghai, Dept Translat Neurosci, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Inst Brain Sci, MOE Frontiers Ctr Brain Sci, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
[3] Tongji Univ, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China
[4] Shanghai Model Organisms Ctr Inc, Shanghai Engn Res Ctr Model Organisms, Shanghai 201203, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; GSDMD; Pyroptosis; Disulfiram; Dopaminergic neuron; Microglia; MPTP MOUSE MODEL; IN-VITRO MODEL; NLRP3; INFLAMMASOME; SUBSTANTIA-NIGRA; GASDERMIN-D; FLUORO-JADE; CELL-DEATH; SUPPRESSION; CASPASE-11; PROTECTS;
D O I
10.1016/j.bbi.2024.03.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
GSDMD-mediated pyroptosis occurs in the nigrostriatal pathway in Parkinson's disease animals, yet the role of GSDMD in neuroinflammation and death of dopaminergic neurons in Parkinson's disease remains elusive. Here, our in vivo and in vitro studies demonstrated that GSDMD, as a pyroptosis executor, contributed to glial reaction and death of dopaminergic neurons across different Parkinson's disease models. The ablation of the Gsdmd attenuated Parkinson's disease damage by reducing dopaminergic neuronal death, microglial activation, and detrimental transformation. Disulfiram, an inhibitor blocking GSDMD pore formation, efficiently curtailed pyroptosis, thereby lessening the pathology of Parkinson's disease. Additionally, a modification in GSDMD was identified in the blood of Parkinson's disease patients in contrast to healthy subjects. Therefore, the detected alteration in GSDMD within the blood of Parkinson's disease patients and the protective impact of disulfiram could be promising for the diagnostic and therapeutic approaches against Parkinson's disease.
引用
收藏
页码:129 / 145
页数:17
相关论文
共 50 条
  • [21] In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease
    Rizzi, Nicoletta
    Brunialti, Electra
    Cerri, Silvia
    Cermisoni, Greta
    Levandis, Giovanna
    Cesari, Nicoletta
    Maggi, Adriana
    Blandini, Fabio
    Ciana, Paolo
    NEUROBIOLOGY OF DISEASE, 2018, 114 : 74 - 84
  • [22] Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    Femminella, Grazia D.
    Ninan, Siddharth
    Atkinson, Rebecca
    Fan, Zhen
    Brooks, David J.
    Edison, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1275 - 1289
  • [23] Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
    Marinova-Mutafchieva, Lilia
    Sadeghian, Mona
    Broom, Lauren
    Davis, John B.
    Medhurst, Andrew D.
    Dexter, David T.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (03) : 966 - 975
  • [24] Microglial and Neuronal Cell Pyroptosis Induced by Oxygen-Glucose Deprivation/Reoxygenation Aggravates Cell Injury via Activation of the Caspase-1/GSDMD Signaling Pathway
    Dong, Zhaofei
    Peng, Qingxia
    Pan, Kuang
    Lin, Weijye
    Wang, Yidong
    NEUROCHEMICAL RESEARCH, 2023, 48 (09) : 2660 - 2673
  • [25] Parkinson's Disease Associated α-Synuclein Familial Mutants Promote Dopaminergic Neuronal Death in Drosophila melanogaster
    Mohite, Ganesh M.
    Dwivedi, Saumya
    Das, Subhadeep
    Kumar, Rakesh
    Paluri, Sravya
    Mehra, Surabhi
    Ruhela, Neha
    Arunima, S.
    Jha, Narendra Nath
    Maji, Samir K.
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (11): : 2628 - 2638
  • [26] Herbal medicine (Hepad) prevents dopaminergic neuronal death in the rat MPTP model of Parkinson's disease
    Kim, Dong Hee
    Choi, Jeong June
    Park, Byung-Jun
    INTEGRATIVE MEDICINE RESEARCH, 2019, 8 (03) : 202 - 208
  • [27] Early inflammatory processes accompanying nigral dopaminergic neuronal death in a rat model of Parkinson's disease
    Henry, V.
    Paille, V.
    Thinard, R.
    Damier, P.
    MOVEMENT DISORDERS, 2006, 21 : S342 - S342
  • [28] Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models
    Iannielli, Angelo
    Bido, Simone
    Folladori, Lucrezia
    Segnali, Alice
    Cancellieri, Cinzia
    Maresca, Alessandra
    Massimino, Luca
    Rubio, Alicia
    Morabito, Giuseppe
    Caporali, Leonardo
    Tagliavini, Francesca
    Musumeci, Olimpia
    Gregato, Giuliana
    Bezard, Erwan
    Carelli, Valerio
    Tiranti, Valeria
    Broccoli, Vania
    CELL REPORTS, 2018, 22 (08): : 2066 - 2079
  • [29] HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models
    Peng Lun
    Tao Ji
    De-Hong Wan
    Xia Liu
    Xiao-Dong Chen
    Shuai Yu
    Peng Sun
    Neural Regeneration Research, 2022, 17 (04) : 887 - 897
  • [30] HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models
    Lun, Peng
    Ji, Tao
    Wan, De-Hong
    Liu, Xia
    Chen, Xiao-Dong
    Yu, Shuai
    Sun, Peng
    NEURAL REGENERATION RESEARCH, 2022, 17 (04) : 887 - 897